Cargando…

Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas

Background: PD-L1 expression differs from 19 to 92% in various cancer subtypes. Its expression carries a worse prognostic value in various malignancies and could also be used as a predictive marker for immune checkpoint inhibitor response. This study aimed to explore the prevalence of PD-L1 expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelany, Mohamed, Barth, Thomas FE., Salem, Dina, Shakweer, Marwa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280295/
https://www.ncbi.nlm.nih.gov/pubmed/34276259
http://dx.doi.org/10.3389/pore.2021.1609804